Literature DB >> 22920350

Magnetic resonance imaging in the evaluation of iron overload: a comparison of MRI, echocardiography and serum ferritin level in patients with β-thalassemia major.

Bibi Shahin Shamsian1, Shadi Abdar Esfahani, Hani Milani, Shahram Akhlaghpoor, Saeid Mojtahedzadeh, Abdollah Karimi, Ahmad Reza Shamshiri, Samin Alavi, Alieh Safari, Nima Rezaei, Mohammad Taghi Arzanian.   

Abstract

PURPOSE: This study aimed to evaluate iron levels in cardiac and hepatic tissues using magnetic resonance imaging (MRI) T2*.
METHODS: Cardiac and hepatic MRI was performed for 93 patients with β-thalassemia major.
RESULTS: Cardiac T2* was in the range of 2.9-56.6 ms. Myocardial siderosis was detected in 44% of patients; 25 patients had moderate and severe siderosis with serum ferritin level (SFL) of 576-10,284 ng/ml. There was a significant correlation between SFL and cardiac T2* (p<.001).
CONCLUSIONS: The effective role of MRI as a noninvasive producible method in measurement of iron concentration in tissues is not accessible with conventional techniques.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920350     DOI: 10.1016/j.clinimag.2011.11.029

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  8 in total

Review 1.  Iron Chelators in Treatment of Iron Overload.

Authors:  Sarina Entezari; Seyedeh Mona Haghi; Narges Norouzkhani; Barsa Sahebnazar; Fatemeh Vosoughian; Diba Akbarzadeh; Muhammad Islampanah; Navid Naghsh; Mohammad Abbasalizadeh; Niloofar Deravi
Journal:  J Toxicol       Date:  2022-05-05

2.  The Role of Cardiovascular Magnetic Resonance (CMR) and Computed Tomography (CCT) in Facilitating Heart Failure Management.

Authors:  R Brandon Stacey; W Gregory Hundley
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08

3.  The application value of ultra-short echo time MRI in the quantification of liver iron overload in a rat model.

Authors:  Qiaoling Wu; Xiuwei Fu; Zhizheng Zhuo; Mingfeng Zhao; Hongyan Ni
Journal:  Quant Imaging Med Surg       Date:  2019-02

Review 4.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01

5.  Evaluation of iron overload by cardiac and liver T2* in β-thalassemia: Correlation with serum ferritin, heart function and liver enzymes.

Authors:  Hengameh Khadivi Heris; Babak Nejati; Khatereh Rezazadeh; Hossein Sate; Roya Dolatkhah; Zohreh Ghoreishi; Ali Esfahani
Journal:  J Cardiovasc Thorac Res       Date:  2021-02-18

6.  Two trade names of deferasirox (Osveral® and Exjade®) in reduction of iron overload parameters in major beta-thalassemia patients: A randomized open labeled clinical trial.

Authors:  Mohammadreza Rafati; Hossein Karami; Bita Lashtoo-Aghaee; Bahareh Lashtoo-Aghaee; Mojdeh Dabirian; Razieh Avan
Journal:  Caspian J Intern Med       Date:  2022

7.  Identifying Gingival Pigmentation Patterns and Skin Color and Its Co-relation With Serum Ferritin Levels in Thalassemic Patients.

Authors:  Shreya Gajjar; Harjot Kaur; Gaurav Girdhar; Ashish Kaur; Chandni Patel; Rupal Mehta; Sushmita Bhakkand; Tanvi Hirani; Surabhi Joshi; Mohammed Irfan; Wan Farizatul Shima Binti Wan Ahmad Fakuradzi; Susmita Sinha; Mainul Haque; Santosh Kumar
Journal:  Cureus       Date:  2022-08-14

8.  Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia.

Authors:  A Eghbali; H Taherahmadi; M Shahbazi; B Bagheri; L Ebrahimi
Journal:  Iran J Ped Hematol Oncol       Date:  2014-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.